[108] In addition, controlled-release formulations may reduce treatment frequency ... plans to evaluate TPMs in patients with peritoneal metastases or carcinomatosis, including pancreatic and ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 biparatopic antibody-drug ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

or primary peritoneal cancer, who have previously been treated with between one and three prior systemic treatment regimens can be treated with ELAHERE. ELAHERE was evaluated in the pivotal SORAYA ...

Leerink Partnrs issued their Q3 2025 earnings estimates for Zentalis Pharmaceuticals in a report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will ...

or primary peritoneal cancer. IMNN-001 is Imunon Inc (IMNN) reports significant progress in ovarian cancer treatment trials, while navigating increased R&D expenses and funding needs. IMNN-001 ...

Feb. 7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer ...

That’s because schizophrenia affects the brain—both cognition and memory—making it more difficult to remember to adhere to a treatment plan. In addition, the condition can cause delusions ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.